![]() Global Telehealth Market - 2025-2033
Overview The Global Telehealth Market reached US$ 118.25 billion in 2024 and is expected to reach US$ 699.95 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033. Tel... もっと見る
SummaryOverviewThe Global Telehealth Market reached US$ 118.25 billion in 2024 and is expected to reach US$ 699.95 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033. Telehealth is the use of digital technologies to access and manage healthcare services remotely. It can be used by individuals from home or by healthcare professionals in rural areas. Telehealth can also be used by healthcare providers to enhance or support healthcare services, such as using computers and mobile devices for remote access or remote care. Market Dynamics: Drivers & Restraints Rising Need for Remote Patient Monitoring The global telehealth market is growing due to the increasing demand for remote patient monitoring. As chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders become more prevalent, healthcare systems are seeking efficient ways to provide continuous care. Remote patient monitoring allows healthcare providers to track patients' vital signs and health data in real-time, reducing healthcare costs and improving patient outcomes. The growing aging population and advancements in wearable devices, mobile health applications, and IoT technologies further increase the demand for remote monitoring solutions. For instance, in July 2024, TeleMedCare launched a remote chronic patient monitoring program with a top health insurance provider in the U.S., covering over 500,000 people in five states. The program, based in Florida, aims to address 300 patients with chronic heart, respiratory, and metabolic conditions like CHF, COPD, diabetes, and hypertension. The program is part of TeleMedCare's two-billion-dollar global health strategy plan, focusing on adaptability to company requirements and protocols. The initial pilot phase is addressing 300 patients with chronic conditions. Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions The global telehealth market faces challenges due to inadequate infrastructure and limited digital literacy in developing regions. Poor internet connections, advanced telecommunications systems, and smart device access hinder telehealth effectiveness. Limited digital literacy also hinders adoption. High costs and government support further hinder market growth. Investments in infrastructure, technology, and education are needed. Segment Analysis The global telehealth market is segmented based on, Component, Delivery Mode, Application, End User and Region. Product Type: Hardware segment is expected to dominate the Telehealth market share The hardware segment holds a major portion of the telehealth market share and is expected to continue to hold a significant portion of the telehealth market share during the forecast period. Hardware is crucial in the global telehealth market, providing essential tools and devices for real-time data collection, analysis, and transmission between patients and healthcare providers. Advancements in hardware technology, such as portable diagnostic devices and IoT-enabled health monitoring gadgets, have improved the accuracy and accessibility of telehealth services. The integration of these devices with cloud platforms and mobile applications enhances the scalability of telehealth solutions, making them more efficient for patients and providers. For instance, in November 2024, Thailand is introduced telehealth kiosks to modernize its healthcare system, allowing patients to measure vital signs like temperature, pulse, respiration, and blood pressure. The collected data is then transmitted to an online system for remote consultations with doctors. The 30-baht universal healthcare scheme allows patients to choose home delivery or pick up from participating pharmacies, aligning with the government's vision of expanding the service into a "30-baht anywhere" service, making quality healthcare more accessible and reducing hospital burden. End User:- Healthcare providers segment is the fastest-growing segment in Telehealth market share The healthcare providers segment is the fastest-growing segment in the telehealth market share and is expected to hold the market share over the forecast period. Healthcare providers are driving the global telehealth market by promoting virtual consultations, remote patient monitoring, and follow-up care. They build trust, educate patients about telehealth, and address privacy and usability concerns. Integrating telehealth into routine care reduces the burden on traditional facilities, especially in managing chronic diseases and emergency consultations. Active participation, supported by training programs and government incentives, is crucial in scaling telehealth adoption across different regions and demographics. For instance, in June 2024, Apollo Telehealth and the Government of Manipur have launched a telemedicine-driven primary health center in Borobeka, Manipur, to improve healthcare access for communities affected by recent conflicts. The area, known for its isolation and challenging road conditions, faces significant obstacles to accessing timely medical care and emergency services. The nearest referral hospital is located 90 minutes away in Jiribam, causing prolonged treatment and health concerns. Geographical Analysis North America is expected to hold a significant position in the Telehealth market share North America holds a substantial position in the telehealth market and is expected to hold most of the market share due to its, high adoption of digital health technologies, and focus on cost reduction. The region's high prevalence of chronic diseases like diabetes and cardiovascular disorders makes telehealth an ideal solution. Government policies, such as reimbursement for services and funding programs, encourage adoption. The widespread use of smartphones, high-speed internet, AI, and IoT also accelerates market growth. For instance, in August 2024, Pfizer has launched PfizerForAll, a digital platform designed to simplify healthcare access and health management for Americans. The platform supports Billions affected by common illnesses like migraine, COVID-19, or flu, as well as those seeking adult vaccinations. It consolidates critical resources and services into a single destination, reducing the time and steps needed for important health actions like getting care, filling prescriptions, and finding potential savings on Pfizer medicines. Europe is growing at the fastest pace in the Telehealth market Europe holds the fastest pace in the telehealth market and is expected to hold most of the market share fueled by the need to improve healthcare access in rural areas and reduce the burden on overstretched systems. The aging population in countries like Germany, Italy, and the UK has increased the demand for remote patient monitoring and virtual consultations. The integration of digital technologies, government initiatives, and EHR adoption, along with advancements in telecommunication infrastructure, enhances the efficiency and accessibility of telehealth services. For instance, Doctorsa, a global telehealth platform, has launched in the UK, connecting travellers with local doctors within five minutes. The platform, founded in Italy, has expanded internationally to 33 countries and has served over 100,000 users. Doctorsa connects tourists and UK residents seeking urgent care, especially those facing long waits for GP appointments or needing support outside surgery hours. The platform aims to meet the growing demand for accessible healthcare in the UK. Competitive Landscape The major global players in the telehealth market include Epic Systems Corporation, Oracle Corporation, Veradigm LLC, MEDITECH, McKesson Corporation, GE Healthcare, NXGN Management, LLC, Athenahealth, eClinicalWorks, Greenway Health and among others. Key Developments • In August 2024, VSee Health, Inc. has launched its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together. Aimee offers virtual healthcare, labs, and prescription drugs to patients, regardless of health insurance. The service works with local community centres to transform them into centers of care, providing virtual urgent care, primary care, and medical weight loss with exercise programs to improve the health of residents in Wichita's communities. • In November 2024, MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, has introduced new Telehealth functionality within its MedAdvisor App. This feature was ranked as the third most desirable by pharmacists, according to feedback from its extensive network of pharmacy partners. Telehealth access simplifies the patient healthcare journey, allowing consultations with providers and prescription management from anywhere, at any time. Why Purchase the Report? • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals. • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies. • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes. • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies. • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies. • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players. • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies. • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships. • Regional Growth & Investment: Highlights high-growth regions and investment opportunities. • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery. • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare. • Post-market Surveillance: Uses post-market data to enhance product safety and access. • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D. The global telehealth market report delivers a detailed analysis with 70 key tables, more than 60 visually impactful figures, and 199 pages of expert insights, providing a complete view of the market landscape. Target Audience 2024 • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals. • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists. • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts. • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales. • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts. • Supply Chain: Distribution and Supply Chain Managers. • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies. • Academic & Research: Academic Institutions. Table of Contents1. Methodology and Scope1.1. Research Methodology 1.2. Research Objective and Scope of the Report 2. Definition and Overview 3. Executive Summary 3.1. Snippet by Component 3.2. Snippet by Delivery Mode 3.3. Snippet by Application 3.4. Snippet by End User 3.5. Snippet by Region 4. Dynamics 4.1. Impacting Factors 4.1.1. Drivers 4.1.1.1. Rising Need for Remote Patient Monitoring 4.1.1.2. XX 4.1.2. Restraints 4.1.2.1. Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions 4.1.3. Opportunity 4.1.4. Impact Analysis 5. Industry Analysis 5.1. Porter’s Five Force Analysis 5.2. Supply Chain Analysis 5.3. Pricing Analysis 5.4. Regulatory Analysis 6. By Component 6.1. Introduction 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 6.1.2. Market Attractiveness Index, By Component 6.2. Hardware* 6.2.1. Introduction 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 6.3. Software 6.4. Services 7. By Delivery Mode 7.1. Introduction 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 7.1.2. Market Attractiveness Index, By Delivery Mode 7.2. On-Premise* 7.2.1. Introduction 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 7.3. Cloud-based 8. By Application 8.1. Introduction 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 8.1.2. Market Attractiveness Index, By Application 8.2. Chronic Disease Management* 8.2.1. Introduction 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 8.3. Mental Health & Behavioral Disorders 8.4. Radiology 8.5. Cardiology 8.6. Neurology 8.7. Dermatology 8.8. Others 9. By End User 9.1. Introduction 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 9.1.2. Market Attractiveness Index, By End User 9.2. Healthcare Providers* 9.2.1. Introduction 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%) 9.3. Patients 9.4. Payers 9.5. Others 10. By Region 10.1. Introduction 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region 10.1.2. Market Attractiveness Index, By Region 10.2. North America 10.2.1. Introduction 10.2.2. Key Region-Specific Dynamics 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.2.7.1. U.S. 10.2.7.2. Canada 10.2.7.3. Mexico 10.3. Europe 10.3.1. Introduction 10.3.2. Key Region-Specific Dynamics 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.3.7.1. Germany 10.3.7.2. U.K. 10.3.7.3. France 10.3.7.4. Spain 10.3.7.5. Italy 10.3.7.6. Rest of Europe 10.4. South America 10.4.1. Introduction 10.4.2. Key Region-Specific Dynamics 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.4.7.1. Brazil 10.4.7.2. Argentina 10.4.7.3. Rest of South America 10.5. Asia-Pacific 10.5.1. Introduction 10.5.2. Key Region-Specific Dynamics 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.5.7.1. China 10.5.7.2. India 10.5.7.3. Japan 10.5.7.4. South Korea 10.5.7.5. Rest of Asia-Pacific 10.6. Middle East and Africa 10.6.1. Introduction 10.6.2. Key Region-Specific Dynamics 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 11. Competitive Landscape 11.1. Competitive Scenario 11.2. Market Positioning/Share Analysis 11.3. Mergers and Acquisitions Analysis 12. Company Profiles Key Market Players 12.1. Teladoc Health, Inc* 12.1.1. Company Overview 12.1.2. Product Portfolio 12.1.2.1. Product Description 12.1.2.2. Product Key Performance Indicators (KPIs) 12.1.2.3. Historic and Forecasted Product Sales 12.1.2.4. Product Sales Volume 12.1.3. Financial Overview 12.1.3.1. Company Revenue’s 12.1.3.2. Geographical Revenue Shares 12.1.3.3. Revenue Forecasts 12.1.4. Key Developments 12.1.4.1. Mergers & Acquisitions 12.1.4.2. Key Product Development Activities 12.1.4.3. Regulatory Approvals etc. 12.1.5. SWOT Analysis 12.2. American Well Corporation (Amwell) 12.3. MDLIVE Inc. 12.4. Doctor On Demand, Inc 12.5. Philips Healthcare 12.6. Medtronic plc 12.7. GE Healthcare 12.8. Siemens Healthineers AG 12.9. Epic Systems Corporation 12.10. Doximity * Similar data will be provided for each market player. Emerging Market Players 12.11. Babylon Health* 12.11.1. Pipeline Products Description 12.11.2. Product Key Performance Indicators (KPIs) 12.11.3. Key Activities 12.11.4. Market Entry Timelines 12.11.5. Product Penetration Rate 12.11.6. Sales Estimation and Projections 12.12. K Health 12.13. Hims & Hers Health, Inc 12.14. MyDoc * Similar data will be provided for each market player. LIST NOT EXHAUSTIVE 13. Appendix 13.1. About Us and Services 13.2. Contact Us
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
DataM Intelligence社の医療分野での最新刊レポート
本レポートと同じKEY WORD(telehealth)の最新刊レポート
よくあるご質問DataM Intelligence社はどのような調査会社ですか?DataM Intelligenceは世界および主要地域の広範な市場に関する調査レポートを出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|